HSC PhD student Colleen Deane has recently been very successful in winning an internal grant of £1000 on behalf of Santander to support her PhD research activities. These funds will support accommodation costs allowing Colleen to collaborate with the University of Nottingham on her PhD topic which will be investigating mechanisms regulating muscle mass decline in the elderly. Colleen will be working with world leading researchers in the field of human molecular and metabolic physiology based at the recently awarded MRC/ARUK Centre for Musculoskeletal Ageing. Colleen will also have the opportunity to learn state-of-the-art data analysis techniques which will be sure to equip her for a very successful research career. In addition to developing collaborative links and learning techniques, the results will contribute towards Colleen’s thesis, future publications and conference presentations. Thus the personal and academic outputs are extremely promising with potentially high ramifications for the prevention of age-related muscle loss. For any further information regarding Colleen’s research, please contact her: cdeane@bournemouth.ac.uk











BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease